Modern features of acute bronchitis therapy. The effect and advantages of the dispersible form of antibacterial drugs

Acute bronchitis is one of the most common reasons for patients seeking medical care on an outpatient basis, the incidence of it reaches 30-40% and depends both on seasonality (from late December to early March) and on the epidemiological characteristics of the population under study (children'...

Full description

Saved in:
Bibliographic Details
Main Authors: D. S. Sukhanov, V. S. Maryushkina, D. Y. Azovtsev
Format: Article
Language:Russian
Published: Open Systems Publication 2022-03-01
Series:Лечащий Врач
Subjects:
Online Access:https://journal.lvrach.ru/jour/article/view/900
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849693899943051264
author D. S. Sukhanov
V. S. Maryushkina
D. Y. Azovtsev
author_facet D. S. Sukhanov
V. S. Maryushkina
D. Y. Azovtsev
author_sort D. S. Sukhanov
collection DOAJ
description Acute bronchitis is one of the most common reasons for patients seeking medical care on an outpatient basis, the incidence of it reaches 30-40% and depends both on seasonality (from late December to early March) and on the epidemiological characteristics of the population under study (children's organized groups, military personnel in long-term care facilities) and on the epidemic rise in the incidence of influenza. The actual incidence of acute bronchitis may be higher, which is associated with self-medication and the lack of seeking medical help for mild forms of the disease. This article discusses modern approaches to understanding the problem of acute bronchitis. The decisive role of respiratory viruses in the etiology of this disease, predisposing factors to its development and the main pathogenetic links and mechanisms are emphasized. At the same time, Mycoplasma pneumoniae and Chlamydophila pneumoniae, as well as Bordetella pertussis, are shown to be crucial in the formation of prolonged forms of acute bronchitis due to the long persistence of these microorganisms. Emphasis is placed on pathogenetic and symptomatic therapy, which is sufficient in the treatment of 90% of cases of this disease. Errors and unreasonable prescriptions of antibacterial drugs for acute bronchitis are considered. At the same time, the necessity of etiotropic (antibacterial) therapy in the case of a disease caused by intracellular pathogens, taking into account modern clinical recommendations, is emphasized. Indications for the appointment of macrolides, features and advantages of the clinical use of azithromycin, as well as its non-antibacterial properties are considered. The advantages of the dosage form of the dispersed tablets in comparison with traditional dosage forms for oral administration are evaluated. The pharmacokinetic advantages of dispersible tablets in the form of their improved bioavailability, their favorable safety profile and ease of use in various categories of patients, as well as potentially higher clinical efficacy are analyzed.
format Article
id doaj-art-90c1b82ae3d14d2dac93d1acc5d125cb
institution DOAJ
issn 1560-5175
2687-1181
language Russian
publishDate 2022-03-01
publisher Open Systems Publication
record_format Article
series Лечащий Врач
spelling doaj-art-90c1b82ae3d14d2dac93d1acc5d125cb2025-08-20T03:20:16ZrusOpen Systems PublicationЛечащий Врач1560-51752687-11812022-03-0103707510.51793/OS.2022.25.3.011895Modern features of acute bronchitis therapy. The effect and advantages of the dispersible form of antibacterial drugsD. S. Sukhanov0V. S. Maryushkina1D. Y. Azovtsev2St. Petersburg State Budgetary Healthcare Institution Tuberculosis Dispensary No. 12Federal State Budgetary Educational Institution of Higher Education St. Petersburg State Chemical and Pharmaceutical University of the Ministry of Health of the Russian FederationSt. Petersburg State Budgetary Healthcare Institution Tuberculosis Dispensary № 12Acute bronchitis is one of the most common reasons for patients seeking medical care on an outpatient basis, the incidence of it reaches 30-40% and depends both on seasonality (from late December to early March) and on the epidemiological characteristics of the population under study (children's organized groups, military personnel in long-term care facilities) and on the epidemic rise in the incidence of influenza. The actual incidence of acute bronchitis may be higher, which is associated with self-medication and the lack of seeking medical help for mild forms of the disease. This article discusses modern approaches to understanding the problem of acute bronchitis. The decisive role of respiratory viruses in the etiology of this disease, predisposing factors to its development and the main pathogenetic links and mechanisms are emphasized. At the same time, Mycoplasma pneumoniae and Chlamydophila pneumoniae, as well as Bordetella pertussis, are shown to be crucial in the formation of prolonged forms of acute bronchitis due to the long persistence of these microorganisms. Emphasis is placed on pathogenetic and symptomatic therapy, which is sufficient in the treatment of 90% of cases of this disease. Errors and unreasonable prescriptions of antibacterial drugs for acute bronchitis are considered. At the same time, the necessity of etiotropic (antibacterial) therapy in the case of a disease caused by intracellular pathogens, taking into account modern clinical recommendations, is emphasized. Indications for the appointment of macrolides, features and advantages of the clinical use of azithromycin, as well as its non-antibacterial properties are considered. The advantages of the dosage form of the dispersed tablets in comparison with traditional dosage forms for oral administration are evaluated. The pharmacokinetic advantages of dispersible tablets in the form of their improved bioavailability, their favorable safety profile and ease of use in various categories of patients, as well as potentially higher clinical efficacy are analyzed.https://journal.lvrach.ru/jour/article/view/900acute bronchitisintracellular pathogensantibacterial therapyazithromycindispersible tablets
spellingShingle D. S. Sukhanov
V. S. Maryushkina
D. Y. Azovtsev
Modern features of acute bronchitis therapy. The effect and advantages of the dispersible form of antibacterial drugs
Лечащий Врач
acute bronchitis
intracellular pathogens
antibacterial therapy
azithromycin
dispersible tablets
title Modern features of acute bronchitis therapy. The effect and advantages of the dispersible form of antibacterial drugs
title_full Modern features of acute bronchitis therapy. The effect and advantages of the dispersible form of antibacterial drugs
title_fullStr Modern features of acute bronchitis therapy. The effect and advantages of the dispersible form of antibacterial drugs
title_full_unstemmed Modern features of acute bronchitis therapy. The effect and advantages of the dispersible form of antibacterial drugs
title_short Modern features of acute bronchitis therapy. The effect and advantages of the dispersible form of antibacterial drugs
title_sort modern features of acute bronchitis therapy the effect and advantages of the dispersible form of antibacterial drugs
topic acute bronchitis
intracellular pathogens
antibacterial therapy
azithromycin
dispersible tablets
url https://journal.lvrach.ru/jour/article/view/900
work_keys_str_mv AT dssukhanov modernfeaturesofacutebronchitistherapytheeffectandadvantagesofthedispersibleformofantibacterialdrugs
AT vsmaryushkina modernfeaturesofacutebronchitistherapytheeffectandadvantagesofthedispersibleformofantibacterialdrugs
AT dyazovtsev modernfeaturesofacutebronchitistherapytheeffectandadvantagesofthedispersibleformofantibacterialdrugs